Citations (35)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Ronald S. Duman. (2009) Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues in Clinical Neuroscience 11:3, pages 239-255.
Read now
Read now
Robin Emsley. (2009) Drugs in development for the treatment of schizophrenia. Expert Opinion on Investigational Drugs 18:8, pages 1103-1118.
Read now
Read now
Articles from other publishers (33)
Neha & Suhel Parvez. (2023) Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer’s disease. Ageing Research Reviews 85, pages 101815.
Crossref
Crossref
Tiffany A. Greenwood. 2023. Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework. Cognitive Functioning in Schizophrenia: Leveraging the RDoC Framework
291
314
.
Yongfeng Yang, Luwen Zhang, Dong Guo, Lin Zhang, Hongyan Yu, Qing Liu, Xi Su, Minglong Shao, Men Song, Yan Zhang, Minli Ding, Yanli Lu, Bing Liu, Wenqiang Li, Weihua Yue, Xiaoduo Fan, Ge Yang & Luxian Lv. (2020) Association of DTNBP1 With Schizophrenia: Findings From Two Independent Samples of Han Chinese Population. Frontiers in Psychiatry 11.
Crossref
Crossref
C. Prats, B. Arias, J. Moya-Higueras, E. Pomarol-Clotet, M. Parellada, A. González-Pinto, V. Peralta, M.I. Ibáñez, M. Martín, L. Fañanás & M. Fatjó-Vilas. (2016) Evidence of an Epistatic Effect Between Dysbindin-1 and Neuritin-1 Genes on the Risk for Schizophrenia Spectrum Disorders. European Psychiatry 40, pages 60-64.
Crossref
Crossref
Priya Bawa, Priyamvada Pradeep, Pradeep Kumar, Yahya E. Choonara, Girish Modi & Viness Pillay. (2016) Multi-target therapeutics for neuropsychiatric and neurodegenerative disorders. Drug Discovery Today 21:12, pages 1886-1914.
Crossref
Crossref
Carolina Muguruza, J. Javier Meana & Luis F. Callado. (2016) Group II Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Drugs. Frontiers in Pharmacology 7.
Crossref
Crossref
Tiffany A. Greenwood, Laura C. Lazzeroni, Monica E. Calkins, Robert Freedman, Michael F. Green, Raquel E. Gur, Ruben C. Gur, Gregory A. Light, Keith H. Nuechterlein, Ann Olincy, Allen D. Radant, Larry J. Seidman, Larry J. Siever, Jeremy M. Silverman, William S. Stone, Catherine A. Sugar, Neal R. Swerdlow, Debby W. Tsuang, Ming T. Tsuang, Bruce I. Turetsky & David L. Braff. (2016) Genetic assessment of additional endophenotypes from the Consortium on the Genetics of Schizophrenia Family Study. Schizophrenia Research 170:1, pages 30-40.
Crossref
Crossref
Abdallah Ahnaou, Hilde Lavreysen, Gary Tresadern, Jose M. Cid & Wilhelmus H. Drinkenburg. (2015) mGlu2 Receptor Agonism, but Not Positive Allosteric Modulation, Elicits Rapid Tolerance towards Their Primary Efficacy on Sleep Measures in Rats. PLOS ONE 10:12, pages e0144017.
Crossref
Crossref
Greg C. Bristow, John A. Bostrom, Vahram Haroutunian & Monsheel S. Sodhi. (2015) Sex differences in GABAergic gene expression occur in the anterior cingulate cortex in schizophrenia. Schizophrenia Research 167:1-3, pages 57-63.
Crossref
Crossref
Yongfeng Yang, Wenqiang Li, Hongxing Zhang, Ge Yang, Xiujuan Wang, Minli Ding, Tianzi Jiang & Luxian Lv. (2015) Association Study of N-Methyl-D-Aspartate Receptor Subunit 2B (GRIN2B) Polymorphisms and Schizophrenia Symptoms in the Han Chinese Population. PLOS ONE 10:5, pages e0125925.
Crossref
Crossref
Daniël Kleinloog, Anna Uit den Boogaard, Albert Dahan, René Mooren, Erica Klaassen, Jasper Stevens, Jan Freijer & Joop van Gerven. (2015) Optimizing the glutamatergic challenge model for psychosis, using S(+)-ketamine to induce psychomimetic symptoms in healthy volunteers. Journal of Psychopharmacology 29:4, pages 401-413.
Crossref
Crossref
Naren P. Rao & Ganesan Venkatasubramanian. 2015. Obsessive-Compulsive Symptoms in Schizophrenia. Obsessive-Compulsive Symptoms in Schizophrenia
135
146
.
Yi-Ting Lin, Ming H. Hsieh, Chen-Chung Liu, Tzung-Jeng Hwang, Yi-Ling Chien, Hai-Gwo Hwu & Chih-Min Liu. (2014) A recently-discovered NMDA receptor gene, GRIN3B, is associated with duration mismatch negativity. Psychiatry Research 218:3, pages 356-358.
Crossref
Crossref
Emilio Sacchetti, Catia Scassellati, Alessandra Minelli, Paolo Valsecchi, Cristian Bonvicini, Patrizio Pasqualetti, Alessandro Galluzzo, Rosaria Pioli & Massimo Gennarelli. (2013) Schizophrenia susceptibility and NMDA-receptor mediated signalling: an association study involving 32 tagSNPs of DAO, DAOA, PPP3CC, and DTNBP1genes. BMC Medical Genetics 14:1.
Crossref
Crossref
Mitsumasa Kurita, José L. Moreno, Terrell Holloway, Alexey Kozlenkov, Giuseppe Mocci, Aintzane García-Bea, James B. Hanks, Rachael Neve, Eric J. Nestler, Scott J. Russo & Javier González-Maeso. (2013)
Repressive Epigenetic Changes at the
mGlu2
Promoter in Frontal Cortex of 5-HT
2A
Knockout Mice
. Molecular Pharmacology 83:6, pages 1166-1175.
Crossref
Crossref
George F. Koob & Andreas Zimmer. 2012. Neurobiology of Psychiatric Disorders. Neurobiology of Psychiatric Disorders
137
166
.
Shayne Cox GadShankar S. Gollapudi & Rajan Radhakrishnan. 2010. Pharmaceutical Sciences Encyclopedia. Pharmaceutical Sciences Encyclopedia.
Q Wang, E I Charych, V L Pulito, J B Lee, N M Graziane, R A Crozier, R Revilla-Sanchez, M P Kelly, A J Dunlop, H Murdoch, N Taylor, Y Xie, M Pausch, A Hayashi-Takagi, K Ishizuka, S Seshadri, B Bates, K Kariya, A Sawa, R J Weinberg, S J Moss, M D Houslay, Z Yan & N J Brandon. (2010) The psychiatric disease risk factors DISC1 and TNIK interact to regulate synapse composition and function. Molecular Psychiatry 16:10, pages 1006-1023.
Crossref
Crossref
Monsheel S. Sodhi, Micah Simmons, Robert McCullumsmith, Vahram Haroutunian & James H. Meador-Woodruff. (2011) Glutamatergic Gene Expression Is Specifically Reduced in Thalamocortical Projecting Relay Neurons in Schizophrenia. Biological Psychiatry 70:7, pages 646-654.
Crossref
Crossref
A Vazdarjanova, K Bunting, N Muthusamy & C Bergson. (2011) Calcyon upregulation in adolescence impairs response inhibition and working memory in adulthood. Molecular Psychiatry 16:6, pages 672-684.
Crossref
Crossref
Clarissa L. Waites & Craig C. Garner. (2011) Presynaptic function in health and disease. Trends in Neurosciences 34:6, pages 326-337.
Crossref
Crossref
Monojit Debnath, Karen Doyle, Camilla Langan, Colm McDonald, Brian Leonard & Dara Cannon. (2011) Recent advances in psychoneuroimmunology: Inflammation in psychiatric disorders. Translational Neuroscience 2:2.
Crossref
Crossref
N. D. Mitchell & G. B. Baker. (2010) An update on the role of glutamate in the pathophysiology of depression. Acta Psychiatrica Scandinavica 122:3, pages 192-210.
Crossref
Crossref
Chi-Un Pae, Alberto Chiesa & Alessandro Serretti. (2010) Influence of DAOA gene variants on antipsychotic response after switch to aripiprazole. Psychiatry Research 178:2, pages 430-432.
Crossref
Crossref
Jana Strohmaier, Josef Frank, Jens R. Wendland, Johannes Schumacher, Rami Abou Jamra, Jens Treutlein, Vanessa Nieratschker, René Breuer, Manuel Mattheisen, Stefan Herms, Thomas W. Mühleisen, Wolfgang Maier, Markus M. Nöthen, Sven Cichon, Marcella Rietschel & Thomas G. Schulze. (2010) A reappraisal of the association between Dysbindin (DTNBP1) and schizophrenia in a large combined case–control and family-based sample of German ancestry. Schizophrenia Research 118:1-3, pages 98-105.
Crossref
Crossref
Suat Ying Tan Cherlyn, Puay San Woon, Jian Jun Liu, Wei Yi Ong, Guo Chuan Tsai & Kang Sim. (2010) Genetic association studies of glutamate, GABA and related genes in schizophrenia and bipolar disorder: A decade of advance. Neuroscience & Biobehavioral Reviews 34:6, pages 958-977.
Crossref
Crossref
Jacqueline Blundell, Pascal S. Kaeser, Thomas C. Südhof & Craig M. Powell. (2010) RIM1α and Interacting Proteins Involved in Presynaptic Plasticity Mediate Prepulse Inhibition and Additional Behaviors Linked to Schizophrenia. The Journal of Neuroscience 30:15, pages 5326-5333.
Crossref
Crossref
William P. Gilks, Emma H. Allott, Gary Donohoe, Elizabeth Cummings, Michael Gill, Aiden P. Corvin & Derek W. Morris. (2010) Replicated genetic evidence supports a role for HOMER2 in schizophrenia. Neuroscience Letters 468:3, pages 229-233.
Crossref
Crossref
Cara R. Rabin & Steven J. Siegel. 2010. Behavioral Neurobiology of Schizophrenia and Its Treatment. Behavioral Neurobiology of Schizophrenia and Its Treatment
141
177
.
José L. Moreno, Stuart C. Sealfon & Javier González-Maeso. (2009) Group II metabotropic glutamate receptors and schizophrenia. Cellular and Molecular Life Sciences 66:23, pages 3777-3785.
Crossref
Crossref
Dion K. DickmanGraeme W. Davis. (2009)
The Schizophrenia Susceptibility Gene
dysbindin
Controls Synaptic Homeostasis
. Science 326:5956, pages 1127-1130.
Crossref
Crossref
Brian Kirkpatrick. (2009) EL CONCEPTO DE ESQUIZOFRENIA. Revista de Psiquiatría y Salud Mental 2:3, pages 105-107.
Crossref
Crossref
Brian Kirkpatrick. (2009) The Concept of Schizophrenia. Revista de Psiquiatría y Salud Mental (English Edition) 2:3, pages 105-107.
Crossref
Crossref